Information Provided By:
Fly News Breaks for August 21, 2017
AMED
Aug 21, 2017 | 09:12 EDT
BofA/Merrill analyst Joanna Gajuk initiated Amedisys with a Neutral and a $55 price target citing sluggish organic growth due to the proposed reimbursement change for 2019.
News For AMED From the Last 2 Days
There are no results for your query AMED